ID
32533
Beskrivning
Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation
Nyckelord
Versioner (3)
- 2018-11-06 2018-11-06 -
- 2018-11-06 2018-11-06 -
- 2018-11-06 2018-11-06 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
6 november 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059
Premature Ejaculation Disease History
- StudyEvent: ODM
Similar models
Premature Ejaculation Disease History
- StudyEvent: ODM
C0683519 (UMLS CUI-2)
C0574845 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0360105 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C0040464 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
Inga kommentarer